Suraksha Diagnostic Ltd Shows Mixed Technical Signals Amid Sideways Momentum Shift

Technical Trend Overview and Momentum Analysis

Suraksha Diagnostic’s technical trend has evolved from mildly bearish to sideways, signalling a period of consolidation after recent volatility. The daily moving averages remain mildly bearish, suggesting that short-term momentum is still under pressure. However, weekly and monthly indicators paint a more mixed picture. The weekly MACD is mildly bullish, indicating a potential for upward momentum in the near term, while the monthly MACD does not currently provide a clear signal.

The Relative Strength Index (RSI) on a weekly basis remains bearish, reflecting some underlying weakness in price momentum, whereas the monthly RSI is neutral with no definitive signal. This divergence between weekly and monthly RSI readings suggests that while short-term momentum is subdued, longer-term momentum is stabilising.

Bollinger Bands provide a more optimistic outlook, with both weekly and monthly readings bullish. This implies that price volatility is expanding upwards, and the stock may be poised for a breakout if buying interest intensifies. The On-Balance Volume (OBV) indicator supports this view, showing bullish trends on both weekly and monthly charts, indicating that volume is confirming price strength.

Moving Averages and KST Indicator Insights

Daily moving averages remain mildly bearish, with the stock price hovering close to the 50-day and 200-day moving averages, which often act as key support and resistance levels. This proximity suggests a potential inflection point where the stock could either break higher or resume its downward trajectory.

The Know Sure Thing (KST) indicator, a momentum oscillator, is bearish on the weekly timeframe and lacks a clear monthly signal. This bearish weekly KST reading aligns with the RSI’s short-term weakness, reinforcing the notion that momentum is currently constrained despite some bullish signals elsewhere.

Dow Theory and Broader Market Context

According to Dow Theory, the weekly trend is mildly bullish, while the monthly trend is mildly bearish. This conflicting signal highlights the stock’s current indecision phase, where short-term optimism is tempered by longer-term caution. Investors should note that such mixed signals often precede significant price moves, either as a breakout or a breakdown.

Comparing Suraksha Diagnostic’s returns to the Sensex further contextualises its performance. Over the past week, the stock surged 23.15%, vastly outperforming the Sensex’s decline of 0.62%. Over one month, it gained 18.3% against the Sensex’s modest 1.24% rise. Year-to-date, Suraksha Diagnostic has delivered a 14.84% return, contrasting with the Sensex’s 8.46% loss. Even over one year, the stock posted a slight gain of 1.99%, while the Sensex fell 3.21%. These figures underscore the stock’s relative resilience and strength within its sector despite its micro-cap status.

Price Range and Volatility Considerations

Suraksha Diagnostic’s current price of ₹308.00 is approaching its 52-week high of ₹333.65, indicating a recovery from the 52-week low of ₹224.10. Today’s trading range between ₹297.25 and ₹308.00 reflects moderate intraday volatility, consistent with the sideways technical trend. The stock’s ability to hold above the ₹300 mark will be critical for sustaining bullish momentum.

Given the mixed technical signals, traders should watch for confirmation from volume and momentum indicators before committing to directional bets. The bullish OBV readings suggest accumulation, but the bearish weekly RSI and KST caution against premature optimism.

Mojo Score and Rating Upgrade

MarketsMOJO assigns Suraksha Diagnostic a Mojo Score of 64.0, reflecting a Hold rating. This represents an upgrade from the previous Sell grade as of 1 June 2026, signalling improved technical and fundamental outlooks. The micro-cap classification underscores the stock’s higher risk profile, but the recent technical momentum shift and relative outperformance against the Sensex provide a compelling case for cautious optimism.

Investor Takeaway and Outlook

Suraksha Diagnostic Ltd’s recent technical parameter changes highlight a stock in transition. The shift from a mildly bearish to a sideways trend suggests a pause in the downtrend, with potential for either a breakout or further consolidation. The mixed signals from MACD, RSI, and KST indicators warrant a cautious approach, with investors advised to monitor volume trends and moving average crossovers closely.

The stock’s relative outperformance against the Sensex over multiple timeframes, combined with a Mojo Score upgrade to Hold, indicates improving fundamentals and technical resilience. However, the micro-cap status and ongoing short-term bearish momentum caution against aggressive positioning.

For investors seeking exposure to the Healthcare Services sector, Suraksha Diagnostic offers a compelling risk-reward profile, particularly if it can sustain above key moving averages and confirm bullish momentum through volume and oscillator signals. Continued monitoring of weekly and monthly technical indicators will be essential to gauge the sustainability of this sideways phase and potential directional shifts.

Summary of Key Technical Metrics:

• Current Price: ₹308.00 (up 0.44% on 17 Aug 2026)
• 52-Week Range: ₹224.10 - ₹333.65
• MACD: Weekly Mildly Bullish, Monthly Neutral
• RSI: Weekly Bearish, Monthly Neutral
• Bollinger Bands: Weekly & Monthly Bullish
• Moving Averages: Daily Mildly Bearish
• KST: Weekly Bearish, Monthly Neutral
• Dow Theory: Weekly Mildly Bullish, Monthly Mildly Bearish
• OBV: Weekly & Monthly Bullish
• Mojo Score: 64.0 (Hold, upgraded from Sell on 1 Jun 2026)

Investors should weigh these technical insights alongside fundamental analysis to make informed decisions in this evolving market environment.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today